Microdissection is essential for gene expression analysis of irradiated rectal cancer tissues

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 901-906

  Inoue, Yasuhiro ^a   Tanaka, Koji ^a   Yokoe, Takeshi ^a   Saigusa, Susumu ^a   Toiyama, Yuji ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Microdissection; Rectal cancer

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; OROTATE PHOSPHORIBOSYLTRANSFERASE; THYMIDYLATE SYNTHASE; UFT; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MICRODISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER; RECTUM RESECTION; STROMA CELL; TUMOR REGRESSION;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIHYDROURACIL DEHYDROGENASE (NADP); DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROTATE PHOSPHORIBOSYLTRANSFERASE; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; THYMIDYLATE SYNTHASE;

EID: 70350366167     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000515     Document Type: Article

References (26)

1. Díaz-González JA, Calvo FA, Cortés J, et al: Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys 64: 1122-1128, 2006.
2. Benzoni E, Intersimone D, Terrosu G, et al: Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemoradiotherapy and surgery for rectal cancer. J Clin Pathol 59: 505-512, 2006.
3. Braendengen M, Tveit KM, Berglund A, et al: Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in non-resectable rectal cancer. J Clin Oncol 26: 3687-3694, 2008.
4. Trial SRC: Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336: 980-987, 1997.
5. Ahmad NR and Nagle D: Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 84: 1445-1448, 1997.
6. Geng L, Donnelly E, McMahon G, et al: Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61: 2413-2419, 2001.
7. Schneider S, Park DJ, Yang D, et al: Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Pharmacogenet Genomics 16: 555-563, 2006.
8. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors. 5th edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
9. Dworak O, Keilholz L and Hoffmann A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12: 19-23, 1997.
10. Kusunoki M, Yanagi H, Noda M and Yamamura T: The usefulness of pharmacokinetic modulating chemotherapy (UFT plus 5FU) in the treatment of unresectable colorectal carcinomas. Oncol Rep 6: 547-552, 1999.
11. Bijwaard KE, Aguilera NS, Monczak Y, et al: Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 47: 195-201, 2001.
12. Schneider S, Uchida K, Brabender J, et al: Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. J Am Coll Surg 200: 336-344, 2005.
13. Kang SY, Han JH, Lee KJ, et al: Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Clin Cancer Res 13: 4146-4153, 2007.
14. Salonga D, Danenberg KD, Johnson M, et al: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6: 1322-1327, 2000.
15. Leichman CG, Lenz HJ, Leichman L, et al: Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15: 3223-3229, 1997.
16. Ichikawa W, Uetake H, Shirota Y, et al: Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Clin Cancer Res 9: 786-791, 2003.
17. Fujii R, Seshimo A and Kameoka S: Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 8: 72-78, 2003.
18. Giralt J, Eraso A, Armengol M, et al: Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 54: 1460-1465, 2002.
19. Ishigami SI, Arii S, Furutani M, et al: Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78: 1379-1384, 1998.
20. Takahashi T, Shirasawa T, Miyake K, et al: Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun 209: 218-226, 1995.
21. Gupta VK, Jaskowiak NT, Beckett MA, et al: Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J 8: 47-54, 2002.
22. Sugiyama Y, Sugiyama K, Hirai Y, et al: Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol 117: 109-116, 2002.
23. Michel C, Desdouets C, Sacre-Salem B, et al: Liver gene expression profiles of rats treated with clofibric acid: comparison of whole liver and laser capture microdissected liver. Am J Pathol 163: 2191-2199, 2003.
24. De Bruin EC, van de Pas S, Lips EH, et al: Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics 6: 142, 2005.
25. Glynne-Jones R, Wallace M, Livingstone JI and Meyrick-Thomas J: Complete clinical response after preoperative chemoradiation in rectal cancer: is a 'wait and see' policy justified? Dis Colon Rectum 51: 10-19, 2008.
26. Gavioli M, Luppi G, Losi L, et al: Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum 48: 1851-1857, 2005.